Smith Joanne D
Known title: EVP & Chief People OfficerCIK: 0001620414
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Delta Air Lines Cuts 2026 Earnings Outlook. Delta Air Lines recently lowered its earnings forecast for 2026, a move that has prompted questions about the stock's future trajectory. While some analysts, including Morgan Stanley, see significant potential upside due to overlooked factors, the broader airline sector is facing headwinds from rising costs. The company's stock is currently trading near key support levels, reflecting mixed market sentiment following the guidance update.
Transaction History
| FLO | ▲ Buy | Option Exercise | 4,442 | $0 | 12/31/2024 | View on chart |
| DAL | ▼ Sell | Open Market | 19,660 | $1.3M | 11/21/2024 | View on chart |
| DAL | ▼ Sell | Open Market | 4,207 | $255K | 11/7/2024 | View on chart |
| DAL | ▼ Sell | Open Market | 3,431 | $173K | 10/11/2024 | View on chart |
| FLO | ▲ Buy | Option Exercise | 4,660 | $0 | 5/23/2024 | View on chart |
| DAL | ▼ Sell | Open Market | 4,846 | $253K | 5/8/2024 | View on chart |
| DAL | ▼ Sell | Open Market | 4,876 | $205K | 2/27/2024 | View on chart |
| DAL | ▲ Buy | Grant | 29,020 | — | 2/7/2024 | View on chart |
| DAL | ▼ Sell | Tax Withholding | 2,239 | $89K | 2/1/2024 | View on chart |
| DAL | ▼ Sell | Open Market | 3,030 | $101K | 10/19/2023 | View on chart |
| DAL | ▼ Sell | Open Market | 9,390 | $327K | 10/17/2023 | View on chart |
| DAL | ▼ Sell | Open Market | 7,513 | $277K | 5/31/2023 | View on chart |
| DAL | ▼ Sell | Open Market | 4,846 | $186K | 2/28/2023 | View on chart |
| DAL | ▼ Sell | Tax Withholding | 10,783 | $425K | 2/8/2023 | View on chart |
| DAL | ▲ Buy | Grant | 23,907 | — | 2/8/2023 | View on chart |
| DAL | ▼ Sell | Tax Withholding | 2,101 | $84K | 2/1/2023 | View on chart |
| DAL | ▼ Sell | Tax Withholding | 2,035 | $81K | 2/1/2023 | View on chart |
| DAL | ▼ Sell | Open Market | 2,000 | $68K | 10/28/2022 | View on chart |
| DAL | ▼ Sell | Open Market | 7,704 | $320K | 5/31/2022 | View on chart |
| DAL | ▼ Sell | Open Market | 9,024 | $398K | 4/29/2022 | View on chart |
| DAL | ▼ Sell | Open Market | 6,098 | $256K | 4/14/2022 | View on chart |
| DAL | ▼ Sell | Tax Withholding | 11,717 | $514K | 2/9/2022 | View on chart |
| DAL | ▲ Buy | Grant | 25,980 | — | 2/9/2022 | View on chart |
| DAL | ▼ Sell | Tax Withholding | 1,892 | $77K | 2/1/2022 | View on chart |
| DAL | ▼ Sell | Tax Withholding | 6,295 | $255K | 2/1/2022 | View on chart |
| DAL | ▼ Sell | Tax Withholding | 2,327 | $94K | 2/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Flowers Foods faces recall and BNP Paribas downgrade
Flowers Foods is navigating an allergen recall that may impact its 'Better For You' brand image. Compounding this, BNP Paribas maintained an Underperform rating and lowered its price target to $5. The stock currently trades near its 52-week low, reflecting these ongoing challenges.
Flowers Foods faces recall and BNP Paribas downgrade. Flowers Foods is navigating an allergen recall that may impact its 'Better For You' brand image. Compounding this, BNP Paribas maintained an Underperform rating and lowered its price target to $5. The stock currently trades near its 52-week low, reflecting these ongoing challenges.